Top

Published in:

01-12-2021 | Care | Original Article

Goals of care discussions: perceptions of radiation and medical oncologists

Authors: Daniel Hong, Lauren C. Das, Ellen Daily, Stacie K. Levine, Olwen M. Hahn, Stanley L. Liauw, Daniel W. Golden, Christina H. Son

Published in: Supportive Care in Cancer | Issue 12/2021

Abstract

Background

Goals of care discussions (GOCD) are essential when counseling patients with cancer. Respective roles of radiation oncologists (RO) and medical oncologists (MO) in GOCD can be unclear. This study aims to clarify the dynamics and barriers to GOCD.

Methods

Five hundred and fifty-four ROs and 1604 MOs at NCI-designated comprehensive cancer centers were sent an anonymous electronic survey regarding demographics, opinions, training in GOCD, GOCD frequency, and three vignettes. Response formats were Yes/No, Likert-type, and free response. Chi-square and Wilcoxon rank-sum tests were performed. Likert-type scores were reported as median [interquartile range].

Results

There were 76 (13.7%) RO and 153 (9.5%) MO who completed surveys. Sixty-three percent of RO and 66% of MO reported GOCD with > 50% of patients (p = 0.90). GOCD were initiated for declining performance status (74%) and poor life expectancy (69%). More MO (42%) received formal GOCD training compared to RO (18%) (p < 0.01). MO were more comfortable conducting GOCD than RO (p < 0.01). RO-conducted GOCD were rated to be less important by MO compared to RO (p < 0.05). Thirty-six percent of MO reported being “not at all” or “somewhat” comfortable with RO-conducted GOCD. RO-initiated GOCD with new patients were rated less appropriate by RO compared to MO perceptions of RO-initiated GOCD (p < 0.01).

Conclusions

While MO and RO conduct GOCD with similar frequency, MO are more comfortable conducting GOCD and are more likely to have formal training. MO rate importance of RO involvement lower than RO. Further research is needed to understand interdisciplinary dynamics that may impact GOCD and subsequent patient care outcomes.

Available only for authorised users

World Health Organization (2019) WHO definition of palliative care. https://www.who.int/news-room/fact-sheets/detail/palliative-care. Accessed 5/17/21

Hanson LC, Collichio F, Bernard SA, Wood WA, Milowsky M, Burgess E et al (2017) Integrating palliative and oncology care for patients with advanced cancer: a quality improvement intervention. J Palliat Med 20(12):1366–1371. https://doi.org/10.1089/jpm.2017.0100CrossRefPubMedPubMedCentral

Chang S, May P, Goldstein NE, Wisnivesky J, Ricks D, Fuld D et al (2018) A palliative radiation oncology consult service reduces total costs during hospitalization. J Pain Symptom Manage 55(6):1452–1458. https://doi.org/10.1016/j.jpainsymman.2018.03.005CrossRefPubMedPubMedCentral

Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A et al (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721–1730. https://doi.org/10.1016/S0140-6736(13)62416-2CrossRefPubMed

National Institutes of Health. In: Levit L, Balogh E, Nass S, Ganz PA, editors. delivering high-quality cancer care: charting a new course for a system in crisis. Washington (DC): National Academies Press (US); 2013.

Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742. https://doi.org/10.1056/NEJMoa1000678CrossRefPubMed

Secunda K, Wirpsa MJ, Neely KJ, Szmuilowicz E, Wood GJ, Panozzo E et al (2020) Use and meaning of “Goals of Care” in the healthcare literature: a systematic review and qualitative discourse analysis. J Gen Intern Med 35(5):1559–1566. https://doi.org/10.1007/s11606-019-05446-0CrossRefPubMed

Emiloju OE, Djibo DAM, Ford JG (2020) Association between the timing of goals-of-care discussion and hospitalization outcomes in patients with metastatic cancer. Am J Hosp Palliat Care 37(6):433–438. https://doi.org/10.1177/1049909119882891CrossRefPubMed

Odejide OO, Uno H, Murillo A, Tulsky JA, Abel GA (2020) Goals of care discussions for patients with blood cancers: association of person, place, and time with end-of-life care utilization. Cancer 126(3):515–522. https://doi.org/10.1002/cncr.32549CrossRefPubMed

10.

Starr LT, Ulrich CM, Corey KL, Meghani SH (2019) Associations among end-of-life discussions, health-care utilization, and costs in persons with advanced cancer: a systematic review. Am J Hosp Palliat Care 36(10):913–926. https://doi.org/10.1177/1049909119848148CrossRefPubMedPubMedCentral

11.

Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA, Malin JL et al (2012) Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol 30(35):4387–4395. https://doi.org/10.1200/JCO.2012.43.6055CrossRefPubMedPubMedCentral

12.

Wright AA, Zhang B, Ray A, Mack JW, Trice E, Balboni T et al (2008) Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA 300(14):1665–1673. https://doi.org/10.1001/jama.300.14.1665CrossRefPubMedPubMedCentral

13.

Zhang B, Wright AA, Huskamp HA, Nilsson ME, Maciejewski ML, Earle CC et al (2009) Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med 169(5):480–488. https://doi.org/10.1001/archinternmed.2008.587CrossRefPubMedPubMedCentral

14.

Lopez-Acevedo M, Havrilesky LJ, Broadwater G, Kamal AH, Abernethy AP, Berchuck A et al (2013) Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer. Gynecol Oncol 130(1):156–161. https://doi.org/10.1016/j.ygyno.2013.04.010CrossRefPubMed

15.

Marron JM, Cronin AM, Kang TI, Mack JW (2018) Intended and unintended consequences: ethics, communication, and prognostic disclosure in pediatric oncology. Cancer 124(6):1232–1241. https://doi.org/10.1002/cncr.31194CrossRefPubMed

16.

Brighton LJ, Bristowe K (2016) Communication in palliative care: talking about the end of life, before the end of life. Postgrad Med J 92(1090):466–470. https://doi.org/10.1136/postgradmedj-2015-133368CrossRefPubMed

17.

Piggott KL, Patel A, Wong A, Martin L, Patel A, Patel M et al (2019) Breaking silence: a survey of barriers to goals of care discussions from the perspective of oncology practitioners. BMC Cancer 19(1):130. https://doi.org/10.1186/s12885-019-5333-xCrossRefPubMedPubMedCentral

18.

Schofield P, Carey M, Love A, Nehill C, Wein S (2006) ‘Would you like to talk about your future treatment options’? Discussing the transition from curative cancer treatment to palliative care. Palliat Med 20(4):397–406. https://doi.org/10.1191/0269216306pm1156oaCrossRefPubMed

19.

Mack JW, Cronin A, Taback N, Huskamp HA, Keating NL, Malin JL et al (2012) End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med 156(3):204–210. https://doi.org/10.7326/0003-4819-156-3-201202070-00008CrossRefPubMedPubMedCentral

20.

Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL et al (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367(17):1616–1625. https://doi.org/10.1056/NEJMoa1204410CrossRefPubMedPubMedCentral

21.

Slort W, Schweitzer BP, Blankenstein AH, Abarshi EA, Riphagen II, Echteld MA et al (2011) Perceived barriers and facilitators for general practitioner-patient communication in palliative care: a systematic review. Palliat Med 25(6):613–629. https://doi.org/10.1177/0269216310395987CrossRefPubMed

22.

Lam TC, Tseng Y (2019) Defining the radiation oncologist’s role in palliative care and radiotherapy. Ann Palliat Med 8(3):246–63. https://doi.org/10.21037/apm.2018.10.02CrossRefPubMed

23.

Murphy JD, Nelson LM, Chang DT, Mell LK, Le QT (2013) Patterns of care in palliative radiotherapy: a population-based study. J Oncol Pract 9(5):e220–e227. https://doi.org/10.1200/JOP.2012.000835CrossRefPubMed

24.

Janjan NA (1998) An emerging respect for palliative care in radiation oncology. J Palliat Med 1(1):83–88. https://doi.org/10.1089/jpm.1998.1.83CrossRefPubMed

25.

Gross JP, Kruser JM, Moran MR, Kaiser K, Szmuilowicz E, Kircher SM et al (2019) Radiation oncologists’ role in end-of-life care: a perspective from medical oncologists. Pract Radiat Oncol 9(5):362–370. https://doi.org/10.1016/j.prro.2019.04.001CrossRefPubMed

26.

McCloskey SA, Tao ML, Rose CM, Fink A, Amadeo AM (2007) National survey of perspectives of palliative radiation therapy: role, barriers, and needs. Cancer J 13(2):130–137. https://doi.org/10.1097/PPO.0b013e31804675d4CrossRefPubMed

27.

Krishnan M, Racsa M, Jones J, Chittenden E, Schaefer KG, Spektor A et al (2017) Radiation oncology resident palliative education. Pract Radiat Oncol 7(6):e439–e448. https://doi.org/10.1016/j.prro.2017.03.007CrossRefPubMed

28.

Parker GM, LeBaron VT, Krishnan M, Shiloh RY, Spektor A, Hertan L et al (2017) Burden of palliative care issues encountered by radiation oncologists caring for patients with advanced cancer. Pract Radiat Oncol 7(6):e517–e524. https://doi.org/10.1016/j.prro.2017.05.005CrossRefPubMed

29.

Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L et al (2019) The REDCap consortium: building an international community of software platform partners. J Biomed Inform 95:103208. https://doi.org/10.1016/j.jbi.2019.103208CrossRefPubMedPubMedCentral

30.

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381. https://doi.org/10.1016/j.jbi.2008.08.010CrossRefPubMed

31.

Oh J, Dennis K, Lefresne S, Livergant J, McKenzie M (2019) End-of-life discussions in practice survey among Canadian radiation oncologists. Ann Palliat Med 8(4):420–7. https://doi.org/10.21037/apm.2019.06.01CrossRefPubMed

32.

Wei RL, Colbert LE, Jones J, Racsa M, Kane G, Lutz S et al (2017) Palliative care and palliative radiation therapy education in radiation oncology: a survey of US radiation oncology program directors. Pract Radiat Oncol 7(4):234–240. https://doi.org/10.1016/j.prro.2016.11.009CrossRefPubMed

33.

El-Sahwi KS, Illuzzi J, Varughese J, Carusillo N, Ratner ES, Silasi DA et al (2012) A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study. Gynecol Oncol 124(3):471–473. https://doi.org/10.1016/j.ygyno.2011.09.029CrossRefPubMed

34.

Fallowfield L, Lipkin M, Hall A (1998) Teaching senior oncologists communication skills: results from phase I of a comprehensive longitudinal program in the United Kingdom. J Clin Oncol 16(5):1961–1968. https://doi.org/10.1200/JCO.1998.16.5.1961CrossRefPubMed

35.

Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM et al (2017) Integration of palliative care into standard oncology care: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 35(1):96–112. https://doi.org/10.1200/JCO.2016.70.1474CrossRefPubMed

36.

Christakis NA, Lamont EB (2000) Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 320(7233):469–472. https://doi.org/10.1136/bmj.320.7233.469CrossRefPubMedPubMedCentral

37.

Wei RL, Mattes MD, Yu J, Thrasher A, Shu HK, Paganetti H et al (2017) Attitudes of radiation oncologists toward palliative and supportive care in the United States: report on national membership survey by the American Society for Radiation Oncology (ASTRO). Pract Radiat Oncol 7(2):113–119. https://doi.org/10.1016/j.prro.2016.08.017CrossRefPubMed

38.

Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21(1):e18–e28. https://doi.org/10.1016/S1470-2045(19)30718-1CrossRefPubMed

39.

Mojica-Marquez AE, Rodriguez-Lopez JL, Patel AK, Ling DC, Rajagopalan MS, Beriwal S (2020) Physician-predicted prognosis and palliative radiotherapy treatment utilization at the end of life an audit of a large cancer center network. J Pain Symptom Manage 60(5):898-905e7. https://doi.org/10.1016/j.jpainsymman.2020.06.022CrossRefPubMed

40.

Fan W, Yan Z (2010) Factors affecting response rates of the web survey: a systematic review. Comput Hum Behav 26(2):132–139. https://doi.org/10.1016/j.chb.2009.10.015CrossRef

41.

National Institutes of Health: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools (2019). Accessed 10/18 2019.

42.

Koontz BF, Benda R, De Los SJ, Hoffman KE, Huq MS, Morrell R et al (2016) US radiation oncology practice patterns for posttreatment survivor care. Pract Radiat Oncol 6(1):50–56. https://doi.org/10.1016/j.prro.2015.10.002CrossRefPubMed

43.

Dunning D, Heath C, Suls JM (2004) Flawed self-assessment: implications for health, education, and the workplace. Psychol Sci Public Interest 5(3):69–106. https://doi.org/10.1111/j.1529-1006.2004.00018.xCrossRefPubMed

44.

Jordan K, Aapro M, Kaasa S, Ripamonti CI, Scotte F, Strasser F et al (2018) European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol 29(1):36–43. https://doi.org/10.1093/annonc/mdx757CrossRefPubMed

Title: Goals of care discussions: perceptions of radiation and medical oncologists
Authors: Daniel Hong
Lauren C. Das
Ellen Daily
Stacie K. Levine
Olwen M. Hahn
Stanley L. Liauw
Daniel W. Golden
Christina H. Son
Publication date: 01-12-2021
Publisher: Springer Berlin Heidelberg
Keyword: Care
Published in: Supportive Care in Cancer / Issue 12/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-021-06258-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2021

Immune checkpoint inhibitors–related encephalitis in melanoma and non-melanoma cancer patients: a single center experience

Toxicity assessment of concurrent gabapentin/pregabalin administration with high-dose melphalan in autologous hematopoietic cell transplant recipients

Assessment of abuse and related factors in older patients with cancer

The characteristics and related factors of insomnia among postoperative patients with gastric cancer: a cross-sectional survey

Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis

The prevalence, associated factors, clinical impact, and state of diagnosis of delirium in palliative care patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer